2020 Warren Alpert Foundation Prize

For identifying glucagon-like peptides and the development of these peptides as therapeutics for diabetes and short bowel syndrome

The 2020 Warren Alpert Foundation Prize was received by three exceptional scientists for "identifying glucagon-like peptides and leading the field with studies extending from cells to humans, culminating in the development of these peptides as therapeutic agents for treating diabetes and short bowel syndrome. "

_{Joel Habener}_,_{Professor of Medicine at the Harvard Medical School, Associate Physician, Director of the Laboratory of Molecular Endocrinology at the Massachusetts General Hospital}

_{Jens Juul Holst}_,_{Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Denmark}

_{Daniel J. Drucker}_{, Lunenfeld-Tanenbaum Research Instutute, Mt. Sinai Hospital, University of Toronto}

Warren Alpert Foundation Prize Recipients / Warren Alpert Foundation

2020 Warren Alpert Foundation Prize

Joel Habener, Professor of Medicine at the Harvard Medical School, Associate Physician, Director of the Laboratory of Molecular Endocrinology at the Massachusetts General Hospital

Jens Juul Holst, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Denmark

Daniel J. Drucker, Lunenfeld-Tanenbaum Research Instutute, Mt. Sinai Hospital, University of Toronto

_{Joel Habener}_,_{Professor of Medicine at the Harvard Medical School, Associate Physician, Director of the Laboratory of Molecular Endocrinology at the Massachusetts General Hospital}

_{Jens Juul Holst}_,_{Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Denmark}

_{Daniel J. Drucker}_{, Lunenfeld-Tanenbaum Research Instutute, Mt. Sinai Hospital, University of Toronto}